RGEN - Repligen CorporationAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $186.19 | Open | $185.58 |
| Volume | 474.7K | Market Cap | 9.64B |
| Yield | Last Dividend |
| Earnings Scheduled For February 24, 2021 | 02/24/21 |
| Companies Reporting Before The Bell ??? Pinnacle West Capital (NYSE: PNW ) is expected to report quarterly earnings at $0.04 per share on revenue of $... | |
| Protein A Resin Market worth $1.9 billio... | 02/03/21 |
| According to the new market research report "Protein A Resin Market by Product (Agarose-based, Glass/Silica-based), Type (Recombinant Protein A, Natur... | |
| Insider Selling: Repligen Co. (NASDAQ:RG... | 01/09/21 |
| Repligen Co. (NASDAQ:RGEN) CFO Jon Snodgres sold 3,957 shares of the stock in a transaction dated Monday, January 4th. The shares were sold at an aver... | |
| P/E Ratio Insights for Repligen | 12/30/20 |
| In the current session, Repligen Inc. (NASDAQ: RGEN) is trading at $192.31, after a 1.74% increase. Over the past month, the ??? | |
| Return On Capital Employed Overview: Rep... | 11/16/20 |
| Looking at Q3, Repligen (NASDAQ: RGEN) earned $20.96 million, a 7.29% increase from the preceding quarter. Repligen also posted a total of $94.06 mill... | |
| The Daily Biotech Pulse: Urovant In M&A ... | 11/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 12) ALX... | |
| The Week Ahead In Biotech: Supernus, San... | 11/08/20 |
| Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a change of gua... | |
| Repligen Stock: This Little-Known Biotec... | 11/05/20 |
| Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for the company... | |
| The Daily Biotech Pulse: Bluebird Bio Pl... | 11/05/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbo... | |
| Repligen Reports Third Quarter 2020 Fina... | 11/05/20 |
| Reports record quarterly revenue of $94.1 million with strong margin expansionOverall revenue grew 35% year-over-year, with organic growth of 31% Rais... | |
| Waterford biotech bought by US life scie... | 11/03/20 |
| Artesyn Biosolutions has been snapped up by US-headquartered Repligen following two other manufacturing acquisitions. | |
| The Daily Biotech Pulse: Gilead Gets Ful... | 10/23/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 22) Ami... | |
| The Daily Biotech Pulse: J&J Pauses Coro... | 10/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12) 10X... | |
| The Daily Biotech Pulse: Gilead, Lilly C... | 10/08/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7) 10X ... | |
| The Daily Biotech Pulse: Bristol-Myers S... | 10/07/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X ... | |
| The Daily Biotech Pulse: Pfizer, BioNTec... | 10/06/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) 10X ... | |
| Repligen Q2 Earnings Preview (NASDAQ:RGE... | 07/29/20 |
| Repligen (NASDAQ:RGEN) is scheduled to announce Q2 earnings results on Thursday, July 30th, before market open. The consensus EPS Estimate is $0.16 (-... | |
| Repligen (RGEN) Down 0.4% Since Last Ear... | 06/05/20 |
| Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Zacks.com featured highlights include: B... | 05/28/20 |
| Zacks.com featured highlights include: BJs Wholesale Club, Fortinet, Vertex Pharmaceuticals, SPS Commerce and Repligen | |
| The Daily Biotech Pulse: FDA Nod For Roc... | 05/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) ADC ... | |
| The Daily Biotech Pulse: Co-Diagnostics ... | 05/15/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 14) Allo... | |
| Why Repligen (RGEN) Might be Well Poised... | 05/13/20 |
| Repligen (RGEN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. | |
| The Daily Biotech Pulse: Gilead Signs Ma... | 05/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Acce... | |
| The Daily Biotech Pulse: Ayala IPO, Plur... | 05/08/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 7) ??? A... | |
| The Daily Biotech Pulse: FDA Approves No... | 05/07/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adve... | |
| Repligen (RGEN) Beats Q1 Earnings and Re... | 05/06/20 |
| Repligen (RGEN) delivered earnings and revenue surprises of 45.46% and 5.75%, respectively, for the quarter ended March 2020. Do the numbers hold clue... | |
| Analysts Estimate Repligen (RGEN) to Rep... | 04/29/20 |
| Repligen (RGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with ... | |
| The Daily Biotech Pulse: Pfizer Earnings... | 04/28/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) As... | |
| Why Is Repligen (RGEN) Down 12.2% Since ... | 03/21/20 |
| Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| Repligen (RGEN) Stock Down Despite Q4 Ea... | 02/21/20 |
| Repligen's (RGEN) beats on both earnings and revenues in Q4. However, stock declines. | |
| Strong Buy rating | 02/25/21 |
| SVB Leerink maintains Outperform rating and raises Price Target from $220.00 to $250.00 | |
| Date | 2021-02-24 (BMO) | Est. (EPS/Rev.) | $0.31/ 93.88M |
| Actual (EPS/Rev.) | $0.52/ $108.65 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| High Growth Stocks- Long only | Srini Donapati | 70.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
